Antibody therapy of pediatric B-cell lymphoma

about

Antibody therapies for lymphoma in children Antibody therapies for lymphoma in children New targets for antibody therapy of pediatric B cell lymphomas.

P2860

Q24186437-9B2741CE-2212-4EB5-B88B-164CE406133E Q24195106-19C6FA2E-E02D-4351-B1CD-62CB62C2CE32 Q38242984-357FA8DF-8D57-4C69-B68C-F96C99ADB063

P2860

Antibody therapy of pediatric B-cell lymphoma

Item

http://www.wikidata.org/entity/Q36732959

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Antibody therapy of pediatric B-cell lymphoma

@ast

Antibody therapy of pediatric B-cell lymphoma

@en

type

Item

label

Antibody therapy of pediatric B-cell lymphoma

@ast

Antibody therapy of pediatric B-cell lymphoma

@en

prefLabel

Antibody therapy of pediatric B-cell lymphoma

@ast

Antibody therapy of pediatric B-cell lymphoma

@en

P1476

Antibody therapy of pediatric B-cell lymphoma

@en

P2093

Friederike Meyer-Wentrup

http://www.w3.org/2001/XMLSchema#string

Marc Bierings

http://www.w3.org/2001/XMLSchema#string

Verena de Zwart

http://www.w3.org/2001/XMLSchema#string

P2860

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Transfection of the CD20 cell surface molecule into ectopic cell types generates a Ca2+ conductance found constitutively in B lymphocytes

Continuous cultures of fused cells secreting antibody of predefined specificity

CD22 and Siglec-G in B cell function and tolerance

The blockade of immune checkpoints in cancer immunotherapy

Continuous cultures of fused cells secreting antibody of predefined specificity. 1975

Antibody therapy of cancer

Tumor regression in cancer patients by very low doses of a T cell-engaging antibody

Mature B-cell lymphoma/leukemia in children and adolescents: intergroup pathologist consensus with the revised European-American Lymphoma Classification.

A recombinant bispecific single-chain antibody, CD19 x CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes.

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2013.00068

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236130101

http://www.w3.org/2001/XMLSchema#string

P698

23565504

http://www.w3.org/2001/XMLSchema#string

P932

3613754

http://www.w3.org/2001/XMLSchema#string

Antibody therapy of pediatric B-cell lymphoma

about

P2860

P2860

Antibody therapy of pediatric B-cell lymphoma

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932